DARE Daré Bioscience, Inc.
$0.41
Daré Bioscience, Inc. (DARE) Earnings News
Earnings press releases, previews and reviews for Daré Bioscience, Inc. (DARE), newest first. Our most recent is review: Daré Bioscience Misses Badly as DARE to PLAY Slips Again; Early Demand Signals Collide With a Shrinking Cash Cushion.
Monday
November 16, 2026
6:41 PM ET
Daré Bioscience Misses Badly as DARE to PLAY Slips Again; Early Demand Signals Collide With a Shrinking Cash Cushion
Earnings Whispers · Review
Monday
November 16, 2026
4:01 PM ET
Daré Bioscience Reports Third Quarter 2026 Financial Results and Highlights Commercial Execution and Pipeline Advancement
Wednesday
November 11, 2026
1:00 PM ET
Daré Bioscience Faces Its Delivery Quarter as Dare to Play Timing and Cash Take Center Stage
Earnings Whispers · Preview
Tuesday
November 10, 2026
9:00 AM ET
Daré Bioscience to Host Third Quarter 2026 Financial Results and Company Update Conference Call and Webcast on November 16, 2026
Thursday
August 13, 2026
4:01 PM ET
Daré Bioscience Reports Second Quarter 2026 Results and Highlights Commercial Inflection as Multi-Product Women’s Health Strategy Advances
Thursday
August 6, 2026
9:05 AM ET
Daré Bioscience to Host Second Quarter 2026 Financial Results and Company Update Conference Call and Webcast on August 13, 2026